dipivefrin has been researched along with latanoprost in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Alm, A; Greve, E; Hoyng, PF; Rulo, A; Watson, P | 1 |
| Alm, A; Mäepea, O; Widengård, I | 1 |
| Fong, JC; Hong, SJ; Wang, HZ; Wu, KY | 1 |
| Călugăru, D; Călugăru, M | 1 |
2 review(s) available for dipivefrin and latanoprost
| Article | Year |
|---|---|
The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.
Topics: Acetazolamide; Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Muscarinic Agonists; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Timolol | 1997 |
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Drug Combinations; Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2004 |
1 trial(s) available for dipivefrin and latanoprost
| Article | Year |
|---|---|
Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.
Topics: Adrenergic Agonists; Aged; Blood-Aqueous Barrier; Conjunctival Diseases; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Epinephrine; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Permeability; Prostaglandins F, Synthetic | 1998 |
3 other study(ies) available for dipivefrin and latanoprost
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A topical prostaglandin for glaucoma.
Topics: Administration, Topical; Adrenergic Agents; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Cholinergic Agents; Clinical Trials as Topic; Drug Tolerance; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Multicenter Studies as Topic; Parasympathomimetics; Pilocarpine; Prostaglandins F, Synthetic; Timolol | 1996 |
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured | 2003 |